Are the PD-1/PD-L1 Immune Checkpoint Inhibitors Completely Interchangeable in Lung Cancer Management? (BMIC-015) - 102204

Spotlight
Video

Are the PD-1/PD-L1 Immune Checkpoint Inhibitors Completely Interchangeable in Lung Cancer Management? (BMIC-015)

BeaconMedIC has 29 videos Subscribe Here

Loading........
Description: Dr. Jack West addresses the question of whether the data with various PD-1 and PD-L1 inhibitors in lung cancer management can be viewed as a class effect and whether these immune checkpoint inhibitors should be considered interchangeable.
Shared By : BeaconMedIC
Posted on : 11/14/17
Added : 5 months ago
Category : Immunotherapy